Immunoglobulin E (IgE)
Lung Cancer, RET (10q11) Rearrangement, FISH, Tissue
Fusarium moniliforme, IgE
Antimicrobial Susceptibility, AFB/Mycobacteria
Cryptosporidium Antigen, Feces
Complete Blood Cell Count (CBC) with Differential
Oncomine™ Dx Target Test
Calcium Sensing Receptor (CASR) Gene Mutation Analysis
Bone Health and Osteoporosis Management Panel
Cancer Antigen (CA) 125
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Turnaround Time
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now